Insider Buying in BioMarin Pharmaceutical Inc. (BMRN)

On August 31, 2020, David Pyott – Director of BioMarin Pharmaceutical Inc. (BMRN) – purchased 12,800 shares of BMRN at $78.26. His out of pocket cost was $1,001,715.